Eligard and Cyp2d6 polymorphism - from FDA reports


Summary

There is no Cyp2d6 polymorphism reported by people who take Eligard yet. This review analyzes which people have Cyp2d6 polymorphism with Eligard. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Eligard and have Cyp2d6 polymorphism, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Eligard and have Cyp2d6 polymorphism

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On May, 26, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Cyp2d6 polymorphism when taking Eligard?

Eligard

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from Eligard 3,836 users)

Cyp2d6 Polymorphism

Cyp2d6 polymorphism has been reported by people with huntington's disease, schizophrenia, acne, attention deficit hyperactivity disorder, rheumatoid arthritis (latest reports from 18 Cyp2d6 polymorphism patients).

Browse all side effects of Eligard

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Cyp2d6 polymorphism

Cyp2d6 polymorphism

Could your condition cause Cyp2d6 polymorphism

Cyp2d6 polymorphism

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Eligard and have Cyp2d6 polymorphism.

You may be interested in these reviews

More reviews for: Eligard, Cyp2d6 polymorphism